Selective inhibition of mTORC1 through deletion of the RagC/D guanosine triphosphatase–activating protein folliculin arm of mTORC1 has been recently shown to inhibit de novo lipogenesis and protect mice from NAFLD (40). The gene discussed is FLCN; the disease is metabolic dysfunction-associated steatotic liver disease.